AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
1 clinical trials · Condition
◉ Watch AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
| Record | Firm | Date |
|---|---|---|
| Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors (NCT06119347) | First Affiliated Hospital of Wenzhou Medical University | 2020-01-01 |
Track AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs automatically
Every clearance here is in the API, with alerts when new ones post.